doi: 10.3389/fphar.2025.1513406 Received 18 October 2024 Accepted 02 January 2025 Published 23 January 2025 Volume 16 - 2025 Edited by Hua Yang, China Pharmaceutical University, China Reviewed by Giovanni Luca Romano, Kore University of Enna, Italy Xinggang Yang, Shenyang Pharmaceutical University, China Updates Copyright 2025 Yan, Wu, Zhao, Yang, An, Liu and Qi
Quick Answer: Allulose may modestly increase endogenous GLP-1 secretion and could theoretically complement GLP-1 receptor agonist therapy, though robust clinical evidence for combined benefits is currently lacking
When It May Be Worth Considering For Weight Loss GLP-1 medications facilitate weight loss by fundamentally changing how the body signals hunger and processes energy
It helps strengthen the gut barrier, which may reduce inflammation